John Celebi is President at Sensei Biotherapeutics, Inc. (SNSE). They have made 1 open-market trade across 1 company since 2023, most recently 2025-02-19.
CIK 0001843539
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $425 since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SNSE | 105,862 | $1.5M |
Shares reported on the most recent Form 4, priced at the 2025-02-26 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SNSE | BUY | 2023-09-11 | 2023-09-13 | $0.85 | $425 | +4.4% | -4.5% | -16.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.